Superoxides

complement C5a receptor 1 ; Homo sapiens







44 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 17991144 Weak response of porcine C5a receptor towards human C5a in miniature pig endothelial cells and PMNs. 2007 Nov 1
2 16714214 C5a mediates secretion and activation of matrix metalloproteinase 9 from human eosinophils and neutrophils. 2006 Jul 1
3 15888142 Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner. 2005 May 1
4 12065474 Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans. 2002 Jul 2
5 12384495 Identification of a potent and orally active non-peptide C5a receptor antagonist. 2002 Dec 20 1
6 11903498 Complement and its implications in cardiac ischemia/reperfusion: strategies to inhibit complement. 2001 Oct 1
7 10636859 Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses. Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells. 2000 Jan 21 1
8 10917953 Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization. 2000 Aug 1
9 11073107 C5a-stimulated human neutrophils use a subset of beta2 integrins to support the adhesion-dependent phase of superoxide production. 2000 Nov 4
10 11080612 Complement activation in heart diseases. Role of oxidants. 2000 Oct 1
11 10369472 Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release. 1999 May 2
12 10452867 Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability. 1999 Sep 2
13 9605167 Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo. 1998 Jun 1 1
14 7836770 Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. 1995 Feb 15 3
15 7521884 C5a-induced expression of P-selectin in endothelial cells. 1994 Sep 1
16 7986196 Differential activation of dibutyryl cAMP-differentiated HL-60 human leukemia cells by chemoattractants. 1994 Nov 16 1
17 8037361 Presence of C5a-potentiating activity in the plasma of a patient with Kimura's disease. 1994 Apr 2
18 8086769 Neutrophil dysfunction in end-stage renal failure: reduced response to priming by C5a. 1994 May 1
19 8133059 C5a as a model for chemotactic factor-stimulated tyrosine phosphorylation in the human neutrophil. 1994 Mar 1 2
20 8145014 Selective regulation of human neutrophil functions by the cell activation inhibitor CI-959. 1994 Apr 1
21 8147901 Contrasting effects of two arachidonate 5-lipoxygenase inhibitors on formyl-methionyl-leucyl-phenylalanine (fMLP) and complement fragment 5a induced human neutrophil superoxide generation. 1994 Mar 15 3
22 8384238 Oxidative priming of neutrophils by interferon-gamma. 1993 Mar 1
23 1309871 Multiple actions of the leukotriene B4 receptor antagonist SC-41930. 1992 Jan 1
24 1320642 C5a reduces formyl peptide-induced actin polymerization and phosphatidylinositol(3,4,5)trisphosphate formation, but not phosphatidylinositol (4,5) bisphosphate hydrolysis and superoxide production, in human neutrophils. 1992 Jul 15 1
25 1322051 Superoxide responses of endothelial cells to C5a and TNF-alpha: divergent signal transduction pathways. 1992 Jul 5
26 1323530 Priming of human neutrophil functions by tumor necrosis factor: enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe. 1992 Jun 1
27 1330136 Effects of a 5-lipoxygenase inhibitor, AA861, on lipoxygenase metabolism and superoxide anion generation by human polymorphonuclear leukocytes--potentiation of superoxide anion generation by LTB4. 1992 1
28 1356929 Effect of ingested pentoxifylline on neutrophil superoxide anion production. 1992 Nov 2
29 1375201 Effect of adenylate cyclase activators on C5a-induced human neutrophil aggregation, enzyme release and superoxide production. 1992 3
30 1660271 Influence of the anti-inflammatory compound flosulide on granulocyte function. 1991 Oct 24 1
31 1966131 Production of superoxide anion and hydrogen peroxide by human neutrophilic granulocytes during chemotactic migration towards f-Met-Leu-Phe, C5a, leukotriene B4, monocyte-derived chemotaxin/IL-8 and platelet-activating factor. 1990 1
32 2153739 The role of formylpeptide receptors, C5a receptors, and cytosolic-free calcium in neutrophil priming. 1990 Feb 1
33 2839363 Different sensitivities of the responses of human neutrophils stimulated with immune complex and C5a anaphylatoxin to pertussis toxin. 1988 Jul 4 1
34 2846218 Alterations in chemotactic factor-induced responses of neutrophils and monocytes from chronic dialysis patients. 1988 Aug 5
35 3421921 Recruitment of actin to the cytoskeletons of human monocyte-like cells activated by complement fragment C5a. Is protein kinase C involved? 1988 Jun 15 3
36 2820637 Differential effects of nylon fibre adherence on the production of superoxide anion by human polymorphonuclear neutrophilic granulocytes stimulated with chemoattractants, ionophore A23187 and phorbol myristate acetate. 1987 Jul 1
37 2824343 C5a-specific modulation of phagocyte functions in patients with localized bacterial infections. 1987 Aug 1
38 3024757 Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. 1987 Jan 1
39 3002297 Degranulation inhibition. A potential mechanism for control of neutrophil superoxide production in sepsis. 1986 Jan 1
40 3003155 Role of protein kinases in stimulation of human polymorphonuclear leukocyte oxidative metabolism by various agonists. Differential effects of a novel protein kinase inhibitor. 1986 Jan 1
41 2984122 Stimulus interactions in release of superoxide anion (O2-) from human neutrophils. Further evidence for multiple pathways of activation. 1985 Mar 1
42 6252250 Stimulus-specific deactivation of chemotactic factor-induced cyclic AMP response and superoxide generation by human neutrophils. 1980 Oct 3
43 6893656 Complement-induced vascular leukostasis. Its role in tissue injury. 1980 Dec 1
44 181968 Dissociation of phagocytosis, metabolic stimulation and lysosomal enzyme release in human leukocytes. 1976 Feb 1